Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Marex Group LtdMRX · Entity 9106 | Group Head of Clearing | June 01, 2026 | June 04, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Marex Group Ltd
Report date June 01, 2026 · Filed June 04, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 207,288 |
Reported balance
After 2026-06-01 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-06-01 · Sale · Disposed 1,303 · Balance 207,288 F1: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan entered into by the Reporting Person on September 10, 2025. F2: The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $52.775 to $53.77, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| Ordinary SharesSEC Table I · non-derivative | Direct | 207,019 |
Reported balance
After 2026-06-01 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2026-06-01 · Sale · Disposed 269 · Balance 207,019 F1: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan entered into by the Reporting Person on September 10, 2025. F3: The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $53.775 to $54.155, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F4: The number of ordinary shares reported herein includes 150,563 shares underlying deferred bonus plan awards previously granted to the Reporting Person. Each award represents a contingent right to receive one (1) ordinary share of the Issuer upon vesting and settlement of the applicable award. |
Filing footnotes · ownership attribution and instrument terms
F1: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan entered into by the Reporting Person on September 10, 2025.
F2: The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $52.775 to $53.77, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3: The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $53.775 to $54.155, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4: The number of ordinary shares reported herein includes 150,563 shares underlying deferred bonus plan awards previously granted to the Reporting Person. Each award represents a contingent right to receive one (1) ordinary share of the Issuer upon vesting and settlement of the applicable award.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 01, 2026 Filed Jun 4, 2026 01:30 UTC | Marex Group Ltd MRX · Entity 9106 | SaleOrdinary Shares | 269 | $53.98 | $14,520.43 |
DisclosureSEC source: 0001193125-26-256170 · ownership.xml · nonDerivative · entry 2 Texier Thomas · CIK 0002057414 · Group Head of Clearing 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 207,019 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan entered into by the Reporting Person on September 10, 2025. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $53.775 to $54.155, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F4 · balance_after: The number of ordinary shares reported herein includes 150,563 shares underlying deferred bonus plan awards previously granted to the Reporting Person. Each award represents a contingent right to receive one (1) ordinary share of the Issuer upon vesting and settlement of the applicable award. Read SEC document |
| June 01, 2026 Filed Jun 4, 2026 01:30 UTC | Marex Group Ltd MRX · Entity 9106 | SaleOrdinary Shares | 1,303 | $53.22 | $69,345.01 |
DisclosureSEC source: 0001193125-26-256170 · ownership.xml · nonDerivative · entry 1 Texier Thomas · CIK 0002057414 · Group Head of Clearing 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 207,288 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan entered into by the Reporting Person on September 10, 2025. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $52.775 to $53.77, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 22, 2026 Filed May 27, 2026 20:05 UTC | Marex Group Ltd MRX · Entity 9106 | Tax withholdingOrdinary Shares | 19,640 | $54.45 | $1,069,398.00 |
DisclosureSEC source: 0001193125-26-241863 · ownership.xml · nonDerivative · entry 1 Texier Thomas · CIK 0002057414 · Group Head of Clearing 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 208,591 F1 · shares: Represents the number of ordinary shares withheld to satisfy the tax withholding obligation in connection with the vesting of certain previously reported shares underlying deferred bonus plan awards. F2 · price: The price reported represents the closing price of the Issuer's ordinary shares on the Nasdaq Stock Market LLC on May 21, 2026. F3 · balance_after: The number of ordinary shares reported herein includes 150,563 shares underlying deferred bonus plan awards previously granted to the Reporting Person. Each award represents a contingent right to receive one (1) ordinary share of the Issuer upon vesting and settlement of the applicable award. Read SEC document |
| May 01, 2026 Filed May 5, 2026 20:05 UTC | Marex Group Ltd MRX · Entity 9106 | SaleOrdinary Shares | 2,606 | $53.53 | $139,495.79 |
DisclosureSEC source: 0001193125-26-206352 · ownership.xml · nonDerivative · entry 2 Texier Thomas · CIK 0002057414 · Group Head of Clearing 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 228,231 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan entered into by the Reporting Person on September 10, 2025. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $53.42 to $53.72, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F4 · balance_after: The number of ordinary shares reported herein includes 192,348 shares underlying deferred bonus plan awards previously granted to the Reporting Person. Each award represents a contingent right to receive one (1) ordinary share of the Issuer upon vesting and settlement of the applicable award. Read SEC document |
| May 01, 2026 Filed May 5, 2026 20:05 UTC | Marex Group Ltd MRX · Entity 9106 | SaleOrdinary Shares | 11,821 | $52.87 | $624,991.64 |
DisclosureSEC source: 0001193125-26-206352 · ownership.xml · nonDerivative · entry 1 Texier Thomas · CIK 0002057414 · Group Head of Clearing 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 230,837 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan entered into by the Reporting Person on September 10, 2025. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $52.42 to $53.415, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 01, 2026 Filed Apr 2, 2026 20:05 UTC | Marex Group Ltd MRX · Entity 9106 | SaleOrdinary Shares | 4,838 | $43.97 | $212,747.66 |
DisclosureSEC source: 0001193125-26-140052 · ownership.xml · nonDerivative · entry 2 Texier Thomas · CIK 0002057414 · Group Head of Clearing 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 242,658 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan entered into by the Reporting Person on September 10, 2025. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $43.77 to $44.32, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F4 · balance_after: The number of ordinary shares reported herein includes 192,348 shares underlying deferred bonus plan awards previously granted to the Reporting Person. Each award represents a contingent right to receive one (1) ordinary share of the Issuer upon vesting and settlement of the applicable award. Read SEC document |
| April 01, 2026 Filed Apr 2, 2026 20:05 UTC | Marex Group Ltd MRX · Entity 9106 | SaleOrdinary Shares | 9,589 | $43.28 | $414,967.81 |
DisclosureSEC source: 0001193125-26-140052 · ownership.xml · nonDerivative · entry 1 Texier Thomas · CIK 0002057414 · Group Head of Clearing 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 247,496 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan entered into by the Reporting Person on September 10, 2025. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $42.77 to $43.7650 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.